MERTK and atherosclerosis: As the main receptor for efferocytosis, lower MerTK expression would be expected to cause impaired efferocytosis, accumulation of apoptotic and necrotic cells, and inflammation, which are processes associated with atherosclerosis, myocardial infarction, and aneurysm rupture [11,33].